“…Undifferentiated HepaRG human hepatoma cell line (HPR101) was obtained from Biopredic International (Saint Grégoire, France). Cells were (David et al, 2018;Dertinger et al, 2012;Habas et al, 2017;Kirkland et al, 2016;Le Hegarat et al, 2014;Seo et al, 2019;Seo et al, 2020;Bemis et al, 2018 (Habas et al, 2017;Liu et al, 2019;Kirkland et al, 2016;Seo et al, 2019;Seo et al, 2020;Dertinger et al, 2012;Bemis et al (Le Hegarat et al, 2014;Severin et al, 2005;Seo et al, 2019;Seo et al, 2020;Kirkland et al, 2016;Guo et al, 2020) 2 (Fowler et al, 2012;Eichenbaum et al, 2009;Hartmann and Speit, 1997;Hu et al, 2009;NTP, 1993) Ethyl (Monarca et al, 1991;Goncharova et al, 1988;Shelby et al, 1993 (Nohmi, 2018;Morita et al, 2016;Ding et al, 2015;Martins et al, 2012;Schulte-Hubbert et al, 2020;Muller et al, 1994;Villarini et al, 2014 cultured and differentiated at 37 °C in a humidified atmosphere with 5% CO2 according to the supplier's protocol with minor modifications. Briefly, 0.65-0.7 million undifferentiated HepaRG cells were seeded in a 100-mm tissue culture dish and cultured in 10 ml growth medium for 14 days.…”